Huttunen M, Harvima I T
Department of Dermatology, Kuopio University Hospital, POB 1777, 70211 Kuopio, Finland.
Br J Dermatol. 2005 Jun;152(6):1149-60. doi: 10.1111/j.1365-2133.2005.06428.x.
Numerous mast cells are present in chronic leg ulcers. Tryptase and chymase are the major mediators of mast cells, but their significance is mostly dependent on their activity. In addition, the proteinases may affect ulcer epithelialization.
To study levels and activity of tryptase and chymase in wash samples and biopsies from chronic leg ulcers and the possible effect of these proteinases on keratinocyte growth and adherence.
Wash samples were taken from 16 patients and a superficial shave biopsy was taken in eight of these patients; a second biopsy series was obtained from the edge of chronic venous leg ulcers (n = 6).
Significant levels of soluble tryptase activity and histamine, but low levels of chymase activity, were measured in wash samples from chronic ulcers. No tryptase-inhibiting activity, but clear chymase-inhibiting activity, was detected in the wash samples. In superficial wound bed biopsies, relatively marked levels of chymase activity together with histamine and tryptase activity were detected. In the second biopsy series, about 80% of the mast cells belonged to the MC(TC) type (tryptase- and chymase-immunopositive). However, about 55-61% of the chymase-immunopositive cells displayed chymase activity and 64 +/- 17% of the tryptase-positive cells revealed immunoreactivity of alpha(1)-antichymotrypsin. As the activity of chymase and tryptase was detected in the ulcer base in a ratio of 1:8, a preparation containing both chymase and tryptase was partially purified from human skin yielding a similar activity ratio of 1:11-13. Treatment of fibronectin-coated plastic surfaces with this preparation decreased the adherence of cultured human keratinocytes, this effect being attributable mainly to chymase. In 2-day cultures using growth factor/serum-deficient low- or high-calcium medium, the tryptase-chymase preparation inhibited the slow growth and at higher concentrations it even induced detachment of keratinocytes. This effect was attributed to chymase, and it was partially regulated by heparin and histamine.
Even though chymase is partially inactivated in chronic leg ulcers, accumulated mast cells in the close proximity of the epithelium edge and their chymase may impair keratinocyte adherence and migration.
慢性腿部溃疡中存在大量肥大细胞。类胰蛋白酶和糜蛋白酶是肥大细胞的主要介质,但其重要性大多取决于它们的活性。此外,这些蛋白酶可能会影响溃疡的上皮形成。
研究慢性腿部溃疡冲洗样本和活检组织中类胰蛋白酶和糜蛋白酶的水平及活性,以及这些蛋白酶对角质形成细胞生长和黏附的可能影响。
从16例患者中采集冲洗样本,其中8例患者进行了浅表剃毛活检;从慢性下肢静脉溃疡边缘获取了另一组活检组织(n = 6)。
在慢性溃疡的冲洗样本中检测到显著水平的可溶性类胰蛋白酶活性和组胺,但糜蛋白酶活性水平较低。在冲洗样本中未检测到类胰蛋白酶抑制活性,但检测到明显的糜蛋白酶抑制活性。在浅表伤口床活检组织中,检测到相对较高水平的糜蛋白酶活性以及组胺和类胰蛋白酶活性。在另一组活检组织中,约80%的肥大细胞属于MC(TC)型(类胰蛋白酶和糜蛋白酶免疫阳性)。然而,约55 - 61%的糜蛋白酶免疫阳性细胞显示出糜蛋白酶活性,64±17%的类胰蛋白酶阳性细胞显示出α(1)-抗糜蛋白酶的免疫反应性。由于在溃疡底部检测到的糜蛋白酶和类胰蛋白酶活性比例为1:8,从人皮肤中部分纯化了一种同时含有糜蛋白酶和类胰蛋白酶的制剂,其活性比例为1:11 - 13。用该制剂处理纤连蛋白包被的塑料表面会降低培养的人角质形成细胞的黏附,这种作用主要归因于糜蛋白酶。在使用生长因子/血清缺乏的低钙或高钙培养基进行的2天培养中,类胰蛋白酶 - 糜蛋白酶制剂抑制了角质形成细胞的缓慢生长,在较高浓度下甚至诱导角质形成细胞脱离。这种作用归因于糜蛋白酶,并且部分受肝素和组胺调节。
尽管糜蛋白酶在慢性腿部溃疡中部分失活,但上皮边缘附近积聚的肥大细胞及其糜蛋白酶可能会损害角质形成细胞的黏附和迁移。